← Back to Search

Other

The Acute Effects of Caloric Restriction on Anthropometrics, Metabolism, and Cardiovascular Health in Overweight Adults

N/A
Waitlist Available
Led By Stephen Ives, Ph.D.
Research Sponsored by Skidmore College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (days 0 and 4)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of the Plexus 3-Day Reset on weight and metabolism.

Eligible Conditions
  • Obesity
  • Intermittent Fasting

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~(days 0 and 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and (days 0 and 4) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in body weight
Secondary study objectives
Change in augmentation index
Change in body fat (%)
Change in central blood pressure
+15 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pre- post-dietary interventionExperimental Treatment1 Intervention
Single arm pre-post dietary intervention (caloric restriction)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
3 day caloric restriction/metabolic reset
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Skidmore CollegeLead Sponsor
19 Previous Clinical Trials
1,097 Total Patients Enrolled
4 Trials studying Obesity
159 Patients Enrolled for Obesity
Stephen Ives, Ph.D.Principal InvestigatorSkidmore College
~4 spots leftby Dec 2025